Antibody-drug conjugates in precision oncology

Cancer Cell · Published 2026-06-01 · DOI 10.1016/j.ccell.2026.05.004

Free full text

Authors (4)

Barbara Pistilli, Raffaele Colombo, Maria Fernanda Mosele, Sarat Chandarlapaty

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Pistilli, B., Colombo, R., Mosele, M., et al. (2026). Antibody-drug conjugates in precision oncology. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.05.004

Related articles

• Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth · Cancer Cell · 2026 · Same journal
• Bridging clinical gaps in personalized cancer neoantigen vaccines · Cancer Cell · 2026 · Same journal
• Targeting internalization, resistance, and response: Insights from ICARUS-LUNG01 · Cancer Cell · 2026 · Same journal
• When more target antigen expression is less · Cancer Cell · 2026 · Same journal
• Targeting drug-tolerant persister cells: Let’s bring on the TROPs! · Cancer Cell · 2026 · Same journal
• Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes · Cancer Cell · 2026 · Same journal
• Context dependency in cancer neuroscience · Cancer Cell · 2026 · Same journal
• A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma · Cancer Cell · 2026 · Same journal
• Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer · Cancer Cell · 2026 · Same journal
• Whole-genome doubling drives immune evasion by silencing antigen presentation · Cancer Cell · 2026 · Same journal